Pharmacy Expert Sounds Alarm Over Codeine Painkillers and Withdrawal Risks
A senior pharmacy lecturer has issued a critical alert regarding widely used codeine-based painkillers, cautioning that millions in the UK could face severe withdrawal symptoms, including profuse sweating, insomnia, and heightened anxiety, upon discontinuation. These opioid medications, commonly available over the counter, are intended for short-term relief of moderate pain when alternatives like ibuprofen or paracetamol prove ineffective.
The Mechanism and Misconceptions of Over-the-Counter Medications
Dipa Kamdar, a Senior Lecturer in Pharmacy Practice at Kingston University, emphasized in a recent article for The Conversation that many consumers mistakenly believe over-the-counter medicines are inherently safe due to their accessibility in supermarkets and pharmacies. She clarified, "The reality is more complicated. Several commonly used over-the-counter medicines carry a real risk of dependence, misuse or harm when taken in higher than recommended doses, for longer than needed, or for the wrong reasons."
Codeine functions by interacting with the central nervous system and brain to block pain signals, simultaneously alleviating anxiety and stress associated with discomfort. However, Kamdar highlighted that side effects such as drowsiness, constipation, nausea, and dizziness are common, and at elevated doses, codeine can impair coordination and slow breathing, posing significant risks for activities like driving.
Genetic Vulnerabilities and the 'Three-Day Rule'
Certain populations face heightened dangers from codeine use. Ultra-rapid metabolisers, who possess a genetic variant more prevalent among individuals of North African, Middle Eastern, and Oceanian descent, convert codeine into morphine at an accelerated rate. This can trigger dangerous side effects even at standard dosages, making them particularly susceptible.
With repeated use, tolerance develops as the brain's opioid receptors adapt, diminishing the drug's efficacy and potentially leading users to increase their intake, thereby raising the risk of physical dependence. Abrupt cessation can then precipitate withdrawal symptoms, including anxiety, restlessness, sweating, and sleep disturbances.
To mitigate these risks, Kamdar underscored the importance of adhering to a strict 'three-day rule' for most individuals. The Medicines and Healthcare products Regulatory Agency in the UK limits pack sizes to 32 tablets and advises that non-prescription codeine products should not be used for more than three days, emphasizing that they should be taken for "as little time as possible."
Essential NHS Guidelines for Codeine Use
- The most frequent side effects include constipation, nausea, and drowsiness.
- Addiction is a potential risk, but healthcare providers can outline strategies to minimize this threat.
- For usage extending beyond a few weeks, a structured treatment plan detailing gradual discontinuation is recommended.
- Alcohol consumption should be avoided while taking codeine to reduce side effects like sleepiness.
- Codeine is not suitable for children under 12 and should only be administered to those aged 12 to 18 if standard painkillers have failed.
This warning serves as a crucial reminder for the public to exercise caution with readily available pain relief options, prioritizing informed usage and adherence to medical advice to prevent adverse health outcomes.
